-
Maternal thyroid function at 11-13 weeks of gestation.
Ashoor G, Kametas NA, Akolekar R, Guisado J, Nicolaides KH.
Fetal Diagn Ther 2010;27:156-63. -
Maternal thyroid function at 11 to 13 weeks of gestation and subsequent fetal death.
Ashoor G, Maiz N, Rotas M, Jawdat F, Nicolaides KH.
Thyroid 2010;20:989-93. -
Fetal sex determination using circulating cell-free fetal DNA (ccffDNA) at 11 to 13 weeks of gestation.
Akolekar R, Farkas DH, Vanagtmael AL, Bombard AT, Nicolaides KH.
Prenat Diagn 2010;30:918-23. -
Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia.
Akolekar R, Cruz JJ, Foidart JM, Munaut C, Nicolaides KH.
Prenat Diagn 2010;30:191-7. -
Maternal serum placental protein 13 at eleven to thirteen weeks in chromosomally abnormal pregnancies.
Akolekar R, Pérez Penco JM, Skyfta E, Rodríguez Calvo J, Nicolaides KH.
Fetal Diagn Ther 2010;27:72-7. -
The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues.
Wilting J, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Borges J, Stark GB, Alitalo K, Tomarev SI, Niemeyer C, Rossler J.
FASEB J 2002;16:1271-3. -
Cervical screening for preterm delivery.
Welsh A, Nicolaides K.
Curr Opin Obstet Gynecol 2002;14:195-202. -
Elective cerclage vs ultrasound-indicated cerclage in high-risk pregnancies.
To MS, Palaniappan V, Skentou C, Gibb D, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;19:475-7. -
A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta-hCG and PAPP-A.
Spencer K, Nicolaides KH.
Prenat Diagn 2002;22:877-9. -
Congenital nephrotic syndrome presenting with increased nuchal translucency in the first trimester.
Souka AP, Skentou H, Geerts L, Bower S, Nicolaides KH.
Prenat Diagn 2002;22:93-5. -
Congenital lymphedema presenting with increased nuchal translucency at 13 weeks of gestation.
Souka AP, Krampl E, Geerts L, Nicolaides KH.
Prenat Diagn 2002;22:91-2. -
Hypophosphatasia associated with increased nuchal translucency: a report of two affected pregnancies.
Souka AP, Raymond FL, Mornet E, Geerts L, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;20:294-5. -
Blackfan-Diamond anemia and dyserythropoietic anemia presenting with increased nuchal translucency at 12 weeks of gestation.
Souka AP, Bower S, Geerts L, Huggon I, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;20:197-9. -
Prenatal ultrasonographic diagnosis of nasal bone abnormalities in three fetuses with Down syndrome.
Sonek JD, Nicolaides KH.
Am J Obstet Gynecol 2002;186:139-41. -
Impaired vascular reactivity in pregnant women with insulin-dependent diabetes mellitus.
Savvidou MD, Geerts L, Nicolaides KH.
Am J Obstet Gynecol 2002;186:84-8. -
Levels of C-reactive protein in pregnant women who subsequently develop pre-eclampsia.
Savvidou MD, Lees CC, Parra M, Hingorani AD, Nicolaides KH.
BJOG 2002;109:297-301. -
Second-trimester uterine artery Doppler screening in unselected populations: a review.
Papageorghiou AT, Yu CK, Cicero S, Bower S, Nicolaides KH.
J Matern Fetal Neonatal Med 2002;12:78-88. -
Trichorionic triplet pregnancies at 10-14 weeks: outcome after embryo reduction compared to expectant management.
Papageorghiou AT, Liao AW, Skentou C, Sebire NJ, Nicolaides KH.
J Matern Fetal Neonatal Med 2002;11:307-12. -
Increased fetal nuchal translucency at 11-14 weeks.
Nicolaides KH, Heath V, Cicero S.
Prenat Diagn 2002;22:308-15. -
One-stop clinic for assessment of risk of chromosomal defects at 12 weeks of gestation.
Nicolaides KH, Bindra R, Heath V, Cicero S.
J Matern Fetal Neonatal Med 2002;12:9-18.